Nebenwirkungen · Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 11
HOS-118004 · Präparat HOS-094733
Table 3: Adverse reactions reported with the use of hydrochlorothiazide alone Investigations: Not known: electrolyte imbalance (including hypokalaemia and hyponatraemia, see section 4.4), hyperuricaemia, glycosuria, hyperglycaemia, increases in cholesterol and triglycerides Cardiac disorders: Not known: cardiac arrhythmias Blood and lymphatic system Not known: aplastic anaemia, bone marrow depression, disorders: neutropenia/agranulocytosis, haemolytic anaemia, leukopenia, thrombocytopenia Nervous system disorders: Not known: vertigo, paraesthesia, light-headedness, restlessness Eye disorders: Not known: transient blurred vision, xanthopsia, acute myopia and secondary acute angle-closure glaucoma, choroidal effusion Respiratory, thoracic and Very rare: acute respiratory distress syndrome (ARDS) mediastinal disorders: (see section 4.4) Not known: respiratory distress (including pneumonitis and pulmonary oedema) Gastrointestinal disorders: Not known: pancreatitis, anorexia, diarrhoea, constipation, gastric irritation, sialadenitis, loss of appetite Renal and urinary disorders: Not known: interstitial nephritis, renal dysfunction Skin and subcutaneous tissue Not known: anaphylactic reactions, toxic epidermal disorders: necrolysis, necrotizing angiitis (vasculitis, cutaneous vasculitis), cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus, photosensitivity reactions, rash, urticaria Musculoskeletal and connective Not known: weakness, muscle spasm tissue disorders: Vascular disorders: Not known: postural hypotension General disorders and Not known: fever administration site conditions: Hepatobiliary disorders: Not known: jaundice (intrahepatic cholestatic jaundice)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-04T14:02:00Z · SHA-256 a042eb891ea2c5486827adad4aa2697b20f0615135f11f14a4bb7f7559935cbd · Passage 5e56077edccfefbff208550a5e02a123fa9051028b209ea4bf130e8a754e5df4 · Zeichen 4385–7192 im Abschnitt